12 Results for "

HBE Cells

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "HBE Cells" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-114544A
CAS No.: 168982-69-2
Purity:  ≥98.0%
Synonyms: OdDHL
N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL) is a bacterial quorum-sensing signaling molecule produced by P. aeruginosa and strains of the B. cepacia complex .Quorum sensing is a regulatory system used by bacteria for controlling gene expression in response to increasing cell density.N-3-oxo-dodecanoyl-L-Homoserine lactone induces the production of IL-8 in 16HBE human bronchial epithelial cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13017S
CAS No.: 1413431-07-8
Purity:  99.83%
Synonyms: VX-770-d9
Ivacaftor-d9 is a potent CFTR modulator and exhibits an EC50 value of 255 nM for CFTR potentiation in G551D/F508del HBE Cells. Ivacaftor-D9 acts as an orally active and improved deuterated Ivacaftor analog for cystic fibrosis research .
loading...
    loading...
Cat. No.: HY-123349
CAS No.: 13027-33-3
Target:  

Drug Metabolite

Research Areas:  

Cardiovascular Disease

5α-Hydroxy-6-keto cholesterol is major metabolite of β-epoxide (5α,6β-epoxycholesterol) during direct exposure of intact cultured human bronchial epithelial cells (16-HBE) to ozone. 5α-Hydroxy-6-keto cholesterol inhibits cholesterol synthesis with an IC50 of 350 nM .
loading...
    loading...
Cat. No.: HY-169342
CAS No.: 2227484-71-9
Target:  

Sodium Channel

Research Areas:  

Inflammation/Immunology

ETD001 is a long-acting ENaC inhibitor, with an IC50 of 57.5 nM in cultured HBE cells. ETD001 can be used in the study for cystic fibrosis .
loading...
    loading...
Cat. No.: HY-170772
CAS No.: 2450279-41-9
Dual Cathepsin L/JAK-IN-1 (Compound A8) is a dual inhibitor of Cathepsin L (CTSL) and JAK, with IC50 values of 0.68 μM, 337.1 nM, 5.251 nM, 27.29 nM, and 172.6 nM for CTSL, JAK1/2/3, and TYK2, respectively. Dual Cathepsin L/JAK-IN-1 effectively blocks the activation of the MAPK, NF-κB, and JAK/STAT signaling pathways, leading to significant anti-inflammatory therapeutic effects. Dual Cathepsin L/JAK-IN-1 can be used in research on acute lung injury (ALI) .
loading...
    loading...
Cat. No.: HY-13017S1
CAS No.: 1413431-22-7
Synonyms: VX-770-d19
Ivacaftor-d9 is a potent CFTR modulator and exhibits an EC50 value of 255 nM for CFTR potentiation in G551D/F508del HBE Cells. Ivacaftor-D9 acts as an orally active and improved deuterated Ivacaftor analog for cystic fibrosis research .
loading...
    loading...
Cat. No.: HY-145390
CAS No.: 2230697-41-1
Purity:  98.66%
Nrf2 activator-1 is an Nrf2 activator that acts on the Keap1-Nrf2 pathway. Nrf2 activation enhances antioxidant response-related transcription and promotes downstream cytoprotective responses such as NQO1. Nrf2 activator-1 is used in research on Nrf2 signaling and oxidative stress .
loading...
    loading...
Cat. No.: HY-157292
CAS No.: 3002962-69-5
Research Areas:  

Cancer

2E-3-F16 is a anticancer agent. 2E-3-F16 exhibits tumor cell selectivity between NCI-H446 cancer cells and HBE cells. 2E-3-F16 enhances the sensitivity of A549 cells to Cisplatin (HY-17394) .
loading...
    loading...
Cat. No.: HY-147742
CAS No.: 2307699-34-7
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Thi-DPPY (compound 8e) is a potent and orally active JAK3 inhibitor with IC50 values of 62.4, 1.38 nM for BTK, JAK, respectively. Thi-DPPY shows anti-proliferative activity against HBE cells. Thi-DPPY shows anti-inflammatory activity in vivo. Thi-DPPY has the potential for the research of idiopathic pulmonary fibrosis (IPF) .
loading...
    loading...
Cat. No.: HY-182063
CAS No.: 2419496-02-7
Research Areas:  

Inflammation/Immunology

Z226407860 is a RING-box protein 1 (RBX1) inhibitor. Z226407860 reduces house dust mite-induced airway epithelial injury and ROS accumulation by inhibiting RBX1. Z226407860 can be used for the research of asthma .
loading...
    loading...
Cat. No.: HY-124706
CAS No.: 858747-13-4
Target:  

OAT

DRAinh-A250 is an orally active inhibitor of mouse and human SLC26A3 (DRA). DRAinh-A250 inhibits SLC26A3-mediated anion transport, blocks colonic fluid absorption, reduces luminal fluid alkalization in the distal colonic loops of mice, and alleviates Loperamide (HY-156131)-induced constipation in wild-type and cystic fibrosis mice. DRAinh-A250 can be used in the research of constipation and cystic fibrosis-related constipation .
loading...
    loading...
Cat. No.: HY-181676
Target:  

Cathepsin

Research Areas:  

Inflammation/Immunology

Anti-inflammatory agent 113 (compound B5) is a Cathepsin L (CTSL) inhibitor and anti-inflammatory agent with a CTSL IC50 of 5.52 μM. Anti-inflammatory agent 113 suppresses CTSL maturation, attenuates NF-κB and p38 MAPK signaling pathway activation, and binds stably in CTSL’s active site via noncovalent interactions with Asp162, Cys25, and Glu63. Anti-inflammatory agent 113 inhibits pro-inflammatory cytokine (IL-6, IL-8) production, reduces inflammatory cell lung infiltration, and alleviates lung tissue injury. Anti-inflammatory agent 113 can be used for the research of acute lung injury .
loading...
    loading...
  • 1